Literature DB >> 33519826

Case Report: Signal Transducer and Activator of Transcription 3 Gain-of-Function and Spectrin Deficiency: A Life-Threatening Case of Severe Hemolytic Anemia.

Sara Ciullini Mannurita1, Rayan Goda2, Ebe Schiavo2, Maria Luisa Coniglio1, Annachiara Azzali1, Ilaria Fotzi1, Annalisa Tondo1, Veronica Tintori1, Stefano Frenos1, Maria Chiara Sanvito1, Marina Vignoli1, Cristina Luceri2, Elisabetta Bigagli2, Alessia Grassi3, Mario Milco D'Elios3, Claudio Favre1, Eleonora Gambineri1,2.   

Abstract

STAT3 gain-of-function (GOF) mutations can be responsible for an incomplete phenotype mainly characterized by hematological autoimmunity, even in the absence of other organ autoimmunity, growth impairment, or severe infections. We hereby report a case with an incomplete form of STAT3 GOF intensified by a concomitant hereditary hematological disease, which misleads the diagnosis. The patient presented with lymphadenopathy, splenomegaly, hypogammaglobulinemia, and severe autoimmune hemolytic anemia (AIHA) with critical complications, including stroke. A Primary Immune Regulatory Disorders (PIRD) was suspected, and molecular analysis revealed a de novo STAT3 gain-of-function mutation. The response to multiple immune suppressive treatments was ineffective, and further investigations revealed a spectrin deficiency. Ultimately, hematopoietic stem cell transplantation from a matched unrelated donor was able to cure the patient. Our case shows an atypical presentation of STAT3 GOF associated with hereditary spherocytosis, and how achievement of a good long-term outcome depends on a strict clinical and laboratory monitoring, as well as on prompt therapeutic intervention.
Copyright © 2021 Ciullini Mannurita, Goda, Schiavo, Coniglio, Azzali, Fotzi, Tondo, Tintori, Frenos, Sanvito, Vignoli, Luceri, Bigagli, Grassi, D’Elios, Favre and Gambineri.

Entities:  

Keywords:  STAT3 gain-of-function; autoimmune lymphoproliferative syndrome; hematopoietic stem cell transplantation; hemolytic anemia; hereditary spherocytosis; lymphadenopathy; primary immune regulatory disorders; spectrin deficiency

Mesh:

Substances:

Year:  2021        PMID: 33519826      PMCID: PMC7843414          DOI: 10.3389/fimmu.2020.620046

Source DB:  PubMed          Journal:  Front Immunol        ISSN: 1664-3224            Impact factor:   7.561


  14 in total

1.  Association of CYP3A4*18B polymorphisms with the pharmacokinetics of cyclosporine in healthy subjects.

Authors:  Y F Hu; J H Tu; Z R Tan; Z Q Liu; G Zhou; J He; D Wang; H H Zhou
Journal:  Xenobiotica       Date:  2007-03       Impact factor: 1.908

2.  Distinct molecular response patterns of activating STAT3 mutations associate with penetrance of lymphoproliferation and autoimmunity.

Authors:  Sabine Jägle; Maximilian Heeg; Sarah Grün; Anne Rensing-Ehl; Maria Elena Maccari; Christian Klemann; Neil Jones; Kai Lehmberg; Claudia Bettoni; Klaus Warnatz; Bodo Grimbacher; Ariane Biebl; Uwe Schauer; Rosie Hague; Olaf Neth; Andrea Mauracher; Jana Pachlopnik Schmid; Alexandre Fabre; Larysa Kostyuchenko; Marita Führer; Myriam Ricarda Lorenz; Klaus Schwarz; Jan Rohr; Stephan Ehl
Journal:  Clin Immunol       Date:  2019-11-23       Impact factor: 3.969

Review 3.  Alternative cyclosporine metabolic pathways and toxicity.

Authors:  U Christians; K F Sewing
Journal:  Clin Biochem       Date:  1995-12       Impact factor: 3.281

4.  Role of metabolites and calcineurin inhibition on C2 monitoring in renal transplant patients.

Authors:  Nikolaos Karamperis; Pernille Koefoed-Nielsen; Anette Bagger Sørensen; Carsten Højskov; Jørgen Poulsen; Kaj Jørgensen
Journal:  Nephrol Dial Transplant       Date:  2005-01-25       Impact factor: 5.992

5.  Early-onset lymphoproliferation and autoimmunity caused by germline STAT3 gain-of-function mutations.

Authors:  Joshua D Milner; Tiphanie P Vogel; Lisa Forbes; Chi A Ma; Asbjørg Stray-Pedersen; Julie E Niemela; Jonathan J Lyons; Karin R Engelhardt; Yu Zhang; Nermina Topcagic; Elisha D O Roberson; Helen Matthews; James W Verbsky; Trivikram Dasu; Alexander Vargas-Hernandez; Nidhy Varghese; Kenneth L McClain; Lina B Karam; Karen Nahmod; George Makedonas; Emily M Mace; Hanne S Sorte; Gøri Perminow; V Koneti Rao; Michael P O'Connell; Susan Price; Helen C Su; Morgan Butrick; Joshua McElwee; Jason D Hughes; Joseph Willet; David Swan; Yaobo Xu; Mauro Santibanez-Koref; Voytek Slowik; Darrell L Dinwiddie; Christina E Ciaccio; Carol J Saunders; Seth Septer; Stephen F Kingsmore; Andrew J White; Andrew J Cant; Sophie Hambleton; Megan A Cooper
Journal:  Blood       Date:  2014-10-30       Impact factor: 22.113

6.  Short Stature in a Boy with Multiple Early-Onset Autoimmune Conditions due to a STAT3 Activating Mutation: Could Intracellular Growth Hormone Signalling Be Compromised?
.

Authors:  Hana Sediva; Petra Dusatkova; Veronika Kanderova; Barbora Obermannova; Jana Kayserova; Lucie Sramkova; Dana Zemkova; Lenka Elblova; Michal Svaton; Radana Zachova; Stanislava Kolouskova; Eva Fronkova; Zdenek Sumnik; Anna Sediva; Jan Lebl; Stepanka Pruhova
Journal:  Horm Res Paediatr       Date:  2017-03-02       Impact factor: 2.852

7.  Rapid quantification of mixed chimerism using multiplex amplification of short tandem repeat markers and fluorescence detection.

Authors:  C Thiede; M Florek; M Bornhäuser; M Ritter; B Mohr; C Brendel; G Ehninger; A Neubauer
Journal:  Bone Marrow Transplant       Date:  1999-05       Impact factor: 5.483

Review 8.  Hereditary spherocytosis, elliptocytosis, and other red cell membrane disorders.

Authors:  Lydie Da Costa; Julie Galimand; Odile Fenneteau; Narla Mohandas
Journal:  Blood Rev       Date:  2013-05-09       Impact factor: 8.250

9.  Resolution of Disease Phenotypes Resulting from Multilocus Genomic Variation.

Authors:  Jennifer E Posey; Tamar Harel; Pengfei Liu; Jill A Rosenfeld; Regis A James; Zeynep H Coban Akdemir; Magdalena Walkiewicz; Weimin Bi; Rui Xiao; Yan Ding; Fan Xia; Arthur L Beaudet; Donna M Muzny; Richard A Gibbs; Eric Boerwinkle; Christine M Eng; V Reid Sutton; Chad A Shaw; Sharon E Plon; Yaping Yang; James R Lupski
Journal:  N Engl J Med       Date:  2016-12-07       Impact factor: 91.245

Review 10.  Activating mutations of STAT3: Impact on human growth.

Authors:  Mariana Gutiérrez
Journal:  Mol Cell Endocrinol       Date:  2020-08-18       Impact factor: 4.102

View more
  2 in total

Review 1.  Inflammatory profile in cervical cancer: influence of purinergic signaling and possible therapeutic targets.

Authors:  Maria Luiza Mukai Franciosi; Thiago Inácio Teixeira do Carmo; Daniela Zanini; Andréia Machado Cardoso
Journal:  Inflamm Res       Date:  2022-04-04       Impact factor: 4.575

2.  Autoimmune Cytopenias and Dysregulated Immunophenotype Act as Warning Signs of Inborn Errors of Immunity: Results From a Prospective Study.

Authors:  Ebe Schiavo; Beatrice Martini; Enrico Attardi; Filippo Consonni; Sara Ciullini Mannurita; Maria Luisa Coniglio; Marco Tellini; Elena Chiocca; Ilaria Fotzi; Laura Luti; Irene D'Alba; Marinella Veltroni; Claudio Favre; Eleonora Gambineri
Journal:  Front Immunol       Date:  2022-01-04       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.